| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 17.742 | 44.940 | 33.003 | 43.180 | 54.980 | 59.845 | 70.388 | 77.726 | 89.118 |
| Total Income - EUR | - | 17.742 | 44.942 | 33.008 | 43.180 | 54.980 | 60.754 | 70.945 | 77.726 | 89.118 |
| Total Expenses - EUR | - | 10.909 | 25.729 | 22.637 | 26.733 | 24.132 | 29.721 | 48.527 | 54.021 | 55.003 |
| Gross Profit/Loss - EUR | - | 6.833 | 19.213 | 10.371 | 16.446 | 30.848 | 31.033 | 22.418 | 23.705 | 34.115 |
| Net Profit/Loss - EUR | - | 6.443 | 18.677 | 10.041 | 16.014 | 30.527 | 30.485 | 21.732 | 23.084 | 31.514 |
| Employees | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Sasu S. Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 71 | 5.168 | 3.472 | 2.031 | 2.493 | 1.224 | 34.428 | 27.116 | 15.033 |
| Current Assets | - | 7.179 | 17.237 | 7.855 | 15.128 | 29.043 | 30.010 | 41.174 | 45.615 | 42.658 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 8.490 | 0 | 0 | 158 |
| Receivables | - | 2.166 | 16.652 | 7.768 | 11.271 | 12.503 | 9.877 | 31.798 | 41.987 | 35.162 |
| Cash | - | 5.013 | 585 | 87 | 3.857 | 16.540 | 11.642 | 9.376 | 3.629 | 7.338 |
| Shareholders Funds | - | 6.487 | 18.729 | 10.093 | 16.065 | 30.577 | 30.534 | 21.781 | 44.799 | 31.562 |
| Social Capital | - | 45 | 44 | 43 | 0 | 0 | 0 | 41 | 40 | 40 |
| Debts | - | 762 | 3.767 | 1.235 | 1.094 | 959 | 700 | 53.826 | 27.941 | 26.139 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Sasu S. Med Srl